KindlyMD (NASDAQ:NAKA) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of KindlyMD (NASDAQ:NAKA – Free Report) from a sell rating to a hold rating in a research note published on Saturday,Wall Street Zen reports.

A number of other analysts also recently weighed in on the stock. B. Riley Financial increased their price target on shares of KindlyMD from $11.00 to $13.00 and gave the company a “buy” rating in a research report on Tuesday, September 22nd. TD Cowen boosted their price objective on shares of KindlyMD from $1.00 to $17.00 and gave the company a “buy” rating in a report on Monday, July 27th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of KindlyMD in a report on Wednesday, November 4th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, KindlyMD has a consensus rating of “Moderate Buy” and a consensus price target of $19.00.

View Our Latest Stock Report on KindlyMD

KindlyMD Price Performance

NASDAQ:NAKA opened at $4.59 on Friday. KindlyMD has a 1-year low of $3.33 and a 1-year high of $24.21. The business’s 50-day moving average price is $7.80 and its two-hundred day moving average price is $7.47.

KindlyMD (NASDAQ:NAKA – Get Free Report) last posted its earnings results on Friday, November 13th. The company reported $4.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.49) by $4.56. The company had revenue of ($1.93) million during the quarter. KindlyMD had a negative return on equity of 71.15% and a negative net margin of 1,067.93%. Analysts predict that KindlyMD will post -12.94 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO David F. Bailey bought 32,134 shares of the stock in a transaction on Wednesday, August 19th. The stock was purchased at an average price of $5.59 per share, for a total transaction of $179,629.06. Following the acquisition, the chief executive officer owned 32,134 shares in the company, valued at approximately $179,629.06. This trade represents a ? increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 24.08% of the company’s stock.

KindlyMD Company Profile

(Get Free Report)

KindlyMD is a Utah-based healthcare company that provides outpatient medical services, with a focus on integrated care. Its offerings include primary care, behavioral health and treatment for substance use disorders, along with care coordination intended to connect patients with appropriate services. The company serves patients through clinics in Utah and has emphasized care for people with complex or ongoing health needs. KindlyMD combined with Nakamoto Holdings in 2025; the resulting company trades on Nasdaq under the symbol NAKA.

Further Reading

Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.